Tilray (ex Aphria) Stock , TLRY

13.67 -0.02 -0.15%

12:27:09 PM NAS

Plus500. 72% of retail CFD accounts lose money

Loading..
Date Open Close Daily High Daily Low

Price change over selected period: 0% 0

Total Analysts: 19

Buy Ratings: 4 Neutral Ratings: 12 Sell Ratings: 3

Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}

Price *Price Target

Lowest: 4.75 Median: 14.86 Highest: 30.25

  • All
  • Buy
  • Hold
  • Sell
  2021 2022 2023 2024 2025 2026
Revenue - 788 - 1,336 - -
Dividend - 0.00 - 0.00 - -
Dividend Yield (in %) - - - - - -
EPS - -0.15 - 0.23 0.05 -
P/E Ratio -57.16 -87.18 123.99 56.85 261.53 -
EBIT - -37 - 181 244 -
EBITDA - 64 - 203 244 -
Net Profit - -70 - 65 15 247
Net Profit Adjusted - -69 - 19 134 -
Pre-Tax Profit - -129 - 64 17 -
Net Profit (Adjusted) - -25 - 92 - -
EPS (Non-GAAP) ex. SOE - -0.44 - -0.15 - -
EPS (GAAP) - -0.15 - 0.23 0.05 -
Gross Income - 248 - 547 524 -
Cash Flow from Investing - -33 - -57 -54 -57
Cash Flow from Operations - -20 - 169 141 445
Cash Flow from Financing - 0 - 0 -433 -
Cash Flow per Share - 0.09 - - - -
Free Cash Flow - -36 - 18 79 388
Free Cash Flow per Share - 0.04 - 0.47 0.69 0.90
Book Value per Share - -3.05 - - - -
Net Debt - 411 - 575 464 -
Research & Development Exp. - 6 - 7 - -
Capital Expenditure - 34 - 51 61 57
Selling, General & Admin. Exp. - - - 288 - -
Shareholder’s Equity - 4,300 - 4,333 3,864 4,953
Total Assets - 5,734 - 6,052 5,812 6,127
  Previous Quarter Current Quarter Next Quarter
ending 11/30/21
Current Year
ending 05/31/21
Next Year
ending 05/31/22
Earnings Estimates
No. of Analysts - - 8 8 14
Average Estimate - - -0.049 USD -2.429 USD -0.150 USD
Year Ago - - - - -2.429 USD
Publish Date - - 7/28/2021 - -
Revenue Estimates
No. of Analysts - - 13 14 16
Average Estimate - - 195 USD 208 USD 788 USD
Year Ago - - - - 208 USD
Publish Date - - 7/28/2021 - -

* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

*Price and Yield of the Respective Date

Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment sales consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment sales consist of hemp seed, hemp foods, board spectrum hemp extract containing CBD which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.

Risk

  • Low
  • Medium
  • High

Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure.

Owner in %
Freefloat 95.55
Heights Capital Management, Inc. 4.43
ETF Managers Group LLC 3.17
Michael Blue 2.68
Christian Groh 2.29
ETF Managers Group LLC 1.86
Susquehanna Securities LLC 1.46
Pentwater Capital Management LP 1.45
Zevenbergen Capital Investments LLC 1.06
Think Investments LP 1.01
Horizons ETFs Management (Canada), Inc. 0.99
Horizons Marijuana Life Sciences Index ETF 0.90
Michael B. Auerbach 0.84
CNH Partners LLC 0.64
Graham Capital Management LP 0.52

Shareholder percentage totals can add to more than 100% because some holders are included in the free float.

Tell us about you

Find us at the office

Eastmond- Sukel street no. 62, 79540 Hanga Roa, Easter Island

Give us a ring

Jaquelinee Wrate
+74 201 709 645
Mon - Fri, 9:00-15:00

Reach out